medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2025, Number 3

<< Back Next >>

Acta Med 2025; 23 (3)

Cardiovascular risk, Mexican perspective

Flores GMA, Curbelo LM

Language: Spanish
References: 24
Page: 265-269
PDF size: 201.14 Kb.


ABSTRACT

Cardiovascular diseases are a global public health problem. More than eleven million people die each year as a result of cardiovascular diseases, which corresponds to 12.8% of all deaths worldwide. This phenomenon will continue to increase in the coming years, so between 2020 and 2030, an increase of between 20.5 and 24.2 million deaths per year is predicted. The probability of presenting a clinical event (death from a cardiovascular cause) in a given period, generally 10 years, has been defined as the cardiovascular risk (CVR). Various studies in Mexico have reported a prevalence of high to very high cardiovascular risk, with some studies describing up to 15% for men and 11% for women in primary care medical units. Several tools for assessing cardiovascular risk include the Framingham risk model, coronary risk assessment, and the International Society of Hypertension risk assessment; these tools are applied in epidemiological studies and clinical practice. This paper aims to provide an updated view of the behavior of cardiovascular risk in Mexico.


REFERENCES

  1. Guevara JSA, Ramírez OMG, Romero RJDJC, Sarmiento JVC. Actualización de guías y recomendaciones en el manejo de obesidad y riesgo cardiovascular. Domino de Las Ciencias. 2022; 8 (3): 2553-2568. Disponible en: https://doi.org/http://dx.doi.org/10.23857/dc.v8i3

  2. Organización Mundial de la Salud. Estrategia mundial para la prevención y el control de las enfermedades transmisibles. Informe de la Directora General. Ginebra, 2000 (Documento A53/14). Disponible en: https://apps.who.int/gb/ebwha/pdf_files/WHA53/sa14.pdf

  3. Álvarez AE. William Kannel y el estudio Framingham. Rev Cub Med Mil. 2022; 51 (2): e1732. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572022000200001

  4. Webster's New World. Medical Dictionary, 3rd ed. Webster's New World. 2019. Available in: https://www.abebooks.com/9780470189283/Websters-New-World-Medical-Dictionary-0470189282/plp

  5. Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E et al. This paper is a co-publication between European Journal of Preventive Cardiology European Heart Journal Acute Cardiovascular Care and European Journal of Cardiovascular Nursing. risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol. 2019; 26 (14): 1534-1544. doi: 10.1177/2047487319846715. Available in: https://pubmed.ncbi.nlm.nih.gov/31234648/

  6. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951; 41 (3): 279-281. doi: 10.2105/ajph.41.3.279. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525365/

  7. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J. 1998; 19 (10): 1434-1503. doi: 10.1053/euhj.1998.1243. Available in: https://pubmed.ncbi.nlm.nih.gov/9820987/

  8. Paramio Rodríguez A, Rivero Villalba LG, Hernández Navas M. Riesgo cardiovascular global: estudios realizados en la población cubana. Rev Cuba Cardiol Cir Cardiovasc. 2023; 29 (1): e1330. Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1330

  9. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24 (11): 987-1003. doi: 10.1016/s0195-668x(03)00114-3. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12788299/

  10. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63 (25 Pt B): 2935-2959. Disponible en: https://doi.org/10.1016/j.jacc.2013.11.005

  11. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42 (34): 3227-3337. doi: 10.1093/eurheartj/ehab484. Erratum in: Eur Heart J. 2022; 43 (42): 4468. Available in: https://pubmed.ncbi.nlm.nih.gov/34458905/

  12. León-Álvarez J, Pérez-Caballero M. El dilema de las guías de hipertensión arterial. Rev Cubana Med. 2019; 57 (4). Disponible en: https://revmedicina.sld.cu/index.php/med/article/view/409

  13. Armario P, Brotons C, Elosua R, Leciñana MA, Castro A, Clarà A et al. Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica. Angiología. 2020; 72 (spe1): 1-30. Disponible en: Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0003-31702020000600001&lng=es&nrm=iso

  14. Secretaría de Salud. Guía de Práctica Clínica. Diagnóstico y tratamiento de dislipidemias (hipercolesterolemia) en el adulto. México: CENETEC; Actualización 2016. https://bit.ly/3hQl1Md

  15. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140 (11): e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. Erratum in: Circulation. 2019; 140 (11): e649-e650. doi: 10.1161/CIR.0000000000000725. Erratum in: Circulation. 2020; 141 (4): e60. doi: 10.1161/CIR.0000000000000755. Erratum in: Circulation. 2020; 141 (16): e774. doi: 10.1161/CIR.0000000000000771. Available in: https://doi.org/10.1161/CIR.0000000000000678

  16. American Heart Association. Know your risk factors for high blood pressure. Dallas: AHA; 2020. Available in: https://bit.ly/2Xv3D8z

  17. Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One. 2019; 14 (4): e0215219.

  18. Marques da Silva P, Lima MJ, Neves PM, Espiga de Macedo M. Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: The PRECISE study. Rev Port Cardiol (Engl Ed). 2019; 38 (6): 427-437.

  19. García-Jiménez Y, Soto-Ávila DA, Palacios-Tapia A, García-Morales G. Estimación del riesgo cardiovascular con herramienta Globorisk en una Unidad de Medicina Familiar. Aten Fam. 2023; 24 (3): 212-218. Disponible en: https://revistas.unam.mx/index.php/atencion_familiar/article/view/85782

  20. Rios KAJ, Flores LMP, Guillen IT. Riesgo cardiovascular en el adulto mayor con hipertensión y diabetes en una UMF. S F J of Health. 2023; 4 (1): 131-143. Disponible en: https://doi.org/10.46981/sfjhv4n1-011

  21. Pérez PA, Pérez LG, Rodríguez TA, Casas PD. Riesgo cardiovascular en personal médico del instituto mexicano del seguro social. Diotima, Revista Científica de Estudios Transdisciplinaria. 2015; 1 (1): 49-58. Disponible en: http://ri.uaemex.mx/bitstream/handle/20.500.11799/139120/4.-RIESGO-CARDIOVASCULAR-EN-PERSONAL-MEDICO-DEL-INSTITUTO.pdf?sequence=1&isAllowed=y

  22. Cordero-Franco H, Felizardo, Soto-Rivera DE, Salinas-Martínez AM, Álvarez-Ortiz JG. Evaluación del riesgo cardiovascular en trabajadores de atención primaria Revista Médica del Instituto Mexicano del Seguro Social. Revista Médica del Instituto Mexicano del Seguro Social. 2020; 58 (2): 84-91. Disponible en: https://www.redalyc.org/journal/4577/457767703004/457767703004.pdf

  23. Secretaría de Salud. Programa de acción específico. Enferemedades Cardiometabolicas, 2020-2024. 2. Gob.mx. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/714141/PAE_CME_cF.pdf

  24. Secretaría de Salud. Programa de Acción Específico 2007-2012 Riesgo Cardiovascular. Secretaría de Salud de Veracruz. Disponible en: https://www.gob.mx/salud/documentos/programa-de-accion-especifico-2007-2012-riesgo-cardiovascular




2020     |     www.medigraphic.com